Filing Details

Accession Number:
0001209191-23-013159
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-27 16:07:12
Reporting Period:
2023-02-23
Accepted Time:
2023-02-27 16:07:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1831828 Vera Therapeutics Inc. VERA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1184592 C Beth Seidenberg C/O Vera Therapeutics, Inc.
8000 Marina Boulevard, Suite 120
Brisbane CA 94005
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2023-02-23 200 $7.24 1,664,902 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
Footnotes
  1. The shares were purchased as follows: 193 shares by Kleiner Perkins Caufield & Byers XVI, LLC ("KPCB XVI") and 7 shares by KPCB XVI Founders Fund, LLC ("XVI Founders"). All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XVI and XVI Founders is KPCB XVI Associates, LLC ("XVI Associates"). L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI and XVI Founders. Such managing members disclaim beneficial ownership of all shares held by KPCB XVI and XVI Founders except to the extent of their pecuniary interest therein.
  2. Represents weighted average purchase price. The shares were purchased at prices ranging from $7.22 to $7.25. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
  3. Consists of 1,609,796 shares of Class A Common Stock held by KPCB XVI and 55,106 shares of Class A Common Stock held by XVI Founders.